Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
| ACAD Stock | USD 19.00 0.01 0.05% |
About 55% of ACADIA Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding ACADIA Pharmaceuticals suggests that many traders are impartial. The current market sentiment, together with ACADIA Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use ACADIA Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
ACADIA |
Acadia Pharmaceuticals Inc. today announced that on September 23, 2024, the Board of Directors granted Catherine Owen Adams, Acadias n
Read at businesswire.com
 |
ACADIA Pharmaceuticals Fundamental Analysis
We analyze ACADIA Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACADIA Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACADIA Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
ACADIA Pharmaceuticals is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
ACADIA Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACADIA Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of ACADIA Pharmaceuticals could also be used in its relative valuation, which is a method of valuing ACADIA Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
ACADIA Pharmaceuticals Related Equities
| MDGL | Madrigal Pharmaceuticals | 14.99 | ||||
| ATHA | Athira Pharma | 12.82 | ||||
| HEPA | Hepion Pharmaceuticals | 6.67 | ||||
| TERN | Terns Pharmaceuticals | 1.35 | ||||
| SRPT | Sarepta Therapeutics | 1.32 | ||||
| PTCT | PTC Therapeutics | 1.19 | ||||
| CABA | Cabaletta Bio | 1.02 | ||||
| AKRO | Akero Therapeutics | 0.25 | ||||
| BPMC | Blueprint Medicines | 0.15 | ||||
| FBIO | Fortress Biotech | 0.62 | ||||
| VKTX | Viking Therapeutics | 1.77 | ||||
| KRYS | Krystal Biotech | 3.10 | ||||
| RVPH | Reviva Pharmaceuticals | 4.96 |
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |